Pharmaceutical compositions of near IR closed chain, sulfo-cyanine dyes

US10405753B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10405753-B2
Application numberUS-201514937641-A
CountryUS
Kind codeB2
Filing dateNov 10, 2015
Priority dateNov 10, 2015
Publication dateSep 10, 2019
Grant dateSep 10, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Sterile and non-toxic pharmaceutical compositions of near IR, closed chain, sulfo-cyanine dyes and methods for visualizing tissue under illumination with near-infrared radiation are provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of visualizing tissue in a patient, the method comprising the step of administering a sterile pharmaceutical composition comprising a unit dosage form of a compound having the formula: wherein, R 1 , R 2 , R 3 , and R 4 are each independently hydrogen, C 1-3 alkyl, or —CO 2 T; X is a single bond, —O—, or —S—; subscripts a, b, c, and d are each independently an integer from 1 to 6, and T is a metal ion, H, or a negative charge; wherein the composition is non-toxic, and wherein the unit dosage form delivers to the patient an amount sufficient to visualize tissue; and further comprising imaging the tissue under illumination with near-infrared radiation, and obtaining at least one image of the tissue from the patient using the composition. 2. The method of claim 1 wherein the unit dosage form delivers to the patient an amount between 0.05 and 8 mg/kg. 3. The method of claim 1 further comprising obtaining the image during administration, after administration, or both during and after administration of the composition. 4. The method of claim 1 where the step of administering a sterile pharmaceutical composition is by intravenous injection. 5. The method of claim 1 where the composition is injected into a circulatory system. 6. The method of claim 1 further comprising visualizing a patient area on which surgery is or will be performed, or for viewing a patient area otherwise being examined by a medical professional. 7. The method of claim 6 further comprising performing a surgical procedure on the patient area based on the visualization of the surgical area. 8. The method of claim 6 further comprising viewing a patient area on which an ophthalmic, arthroscopic, laparoscopic, cardiothoracic, muscular, or neuro procedure is or will be performed. 9. The method of claim 1 further comprising obtaining ex vivo images of at least a portion of the patient. 10. The method of claim 1 wherein the compound has the formula: wherein, R 1 , R 2 , R 3 , and R 4 are each independently hydrogen, —CH 3 , or —CO 2 T. 11. The method of claim 1 wherein the compound is:

Assignees

Inventors

Classifications

  • Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations A61K49/18; preparations containing radioactive substances A61K51/12)} · CPC title

  • the substituent being bound through an oxygen atom · CPC title

  • the polymethine chain being part of a carbocyclic ring,(e.g. benzene, naphtalene, cyclohexene, cyclobutenene-quadratic acid) · CPC title

  • A61B5/0082Primary

    adapted for particular medical purposes · CPC title

  • more than five >CH- groups · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10405753B2 cover?
Sterile and non-toxic pharmaceutical compositions of near IR, closed chain, sulfo-cyanine dyes and methods for visualizing tissue under illumination with near-infrared radiation are provided.
Who is the assignee on this patent?
Intuitive Surgical Operations
What technology area does this patent fall under?
Primary CPC classification C09B23/0025. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).